Dr. Francoeur has been an attending physician in both internal medicine and critical care, as well as a clinical professor at the CHU de Québec – Laval University, since 2014. He joined the Population Health and Optimal Health Practice Research Unit at the CHU de Québec-Laval University in 2017 as a research associate. After receiving his medical degree in 2007 from Université de Sherbrooke, he trained in internal medicine at Laval University in Quebec, and in critical care medicine at the University of Montreal. He completed his master’s degree in epidemiology at the Columbia University of New York in 2016, as well as a clinical fellowship training in neurocritical care at Mount Sinai Hospital, also in New York.
Dr. Francoeur’s research focuses mainly on neurocritical care. Treatment and prevention of secondary insults in patients suffering severe brain injury and optimization of neuroresuscitation are the mainstay of his research efforts.
1401, 18e Rue
Québec, Québec
Canada G1J 1Z4
Latest news
Data not available
Stress Ulcer Prophylaxis during Invasive Mechanical Ventilation
Journal ArticleN Engl J Med, 391 (1), 2024.
Frequency of Screening and Spontaneous Breathing Trial Techniques: A Randomized Clinical Trial
Journal ArticleJAMA, 2024.
Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury
Journal ArticleN Engl J Med, 391 (8), 2024.
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial
Journal ArticleIntensive Care Med, 49 (3), 2023.
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial
Journal ArticleJAMA, 329 (1), 2023.
Simvastatin in Critically Ill Patients with Covid-19
Journal ArticleN Engl J Med, 389 (25), 2023.
Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials
Journal ArticleJAMA, 330 (18), 2023.
IV Vitamin C in Adults With Sepsis: A Bayesian Reanalysis of a Randomized Controlled Trial
Journal ArticleCrit Care Med, 51 (8), 2023.
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial
Journal ArticleIntensive Care Med, 49 (11), 2023.
The authors reply
Journal ArticleCrit Care Med, 51 (12), 2023.
Recently finished projects
- BRAINapt: TBI International Platform Trial, from 2023-10-01 to 2024-03-31
- The NeurO2 study: optimal brain oxygenation in neurocritically ill patients, from 2020-10-01 to 2024-03-31